Literature DB >> 16437609

Hemoconcentration is a poor predictor of severity in acute pancreatitis.

José M Remes-Troche1, Andrés Duarte-Rojo, Gustavo Morales, Guillermo Robles-Díaz.   

Abstract

AIM: To determine whether the hematocrit (Hct) at admission or at 24 h after admission was associated with severe acute pancreatitis (AP), organ failure (OF), and pancreatic necrosis.
METHODS: A total of 336 consecutive patients with a first AP episode were studied. Etiology, Hct values at admission and at 24 h, development of severe AP according to Atlanta's criteria, pancreatic necrosis, OF and mortality were recorded. Hemoconcentration was defined as Hct level >44% for males and >40% for females. The t-test and chi2 test were used to assess the association of hemoconcentration to the severity, necrosis and OF. Diagnostic accuracy was also determined.
RESULTS: Biliary disease was the most frequent etiology (n = 148). Mean Hct levels at admission were 41+/-6% for females and 46+/-7% for males (P<0.01). Seventy-eight (23%) patients had severe AP, and OF developed in 45 (13%) patients. According to contrast-enhanced computed tomography scan, 36% (54/150) patients showed pancreatic necrosis. Hct levels were elevated in 58% (55/96) and 61% (33/54) patients with interstitial and necrotizing pancreatitis, respectively. Neither Hct levels at admission nor hemoconcentration at 24 h were associated with the severity, necrosis or OF. Sensitivity, specificity and positive predictive values for both determinations were very low; and negative predictive values were between 61% and 86%, being the highest value for OF.
CONCLUSION: Hct is not a useful marker to predict a worse outcome in acute pancreatitis. In spite of the high negative predictive value of hemoconcentration, the prognosis gain is limited due to an already high incidence of mild disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437609      PMCID: PMC4717047          DOI: 10.3748/wjg.v11.i44.7018

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  ACUTE PANCREATITIS. THE SIGNIFICANCE OF HEMOCONCENTRATION AT ADMISSION TO THE HOSPITAL.

Authors:  S H GRAY; L D ROSENMAN
Journal:  Arch Surg       Date:  1965-09

2.  Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis.

Authors:  A Brown; J Orav; P A Banks
Journal:  Pancreas       Date:  2000-05       Impact factor: 3.327

3.  Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis.

Authors:  C C Chen; S S Wang; F Y Lee; F Y Chang; S D Lee
Journal:  Am J Gastroenterol       Date:  1999-01       Impact factor: 10.864

Review 4.  Etiological and prognostic factors in human acute pancreatitis: a review.

Authors:  J H Ranson
Journal:  Am J Gastroenterol       Date:  1982-09       Impact factor: 10.864

5.  Red cell indices in normal adults residing at altitude from sea level to 2670 meters.

Authors:  G J Ruíz-Argüelles; L Sánchez-Medal; A Loría; J Piedras; M S Córdova
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

6.  Relationship of necrosis to organ failure in severe acute pancreatitis.

Authors:  S Tenner; G Sica; M Hughes; E Noordhoek; S Feng; M Zinner; P A Banks
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

7.  Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis.

Authors:  C Bassi; M Falconi; G Talamini; G Uomo; G Papaccio; C Dervenis; R Salvia; E B Minelli; P Pederzoli
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

8.  Acute pancreatitis: prognostic value of CT.

Authors:  E J Balthazar; J H Ranson; D P Naidich; A J Megibow; R Caccavale; M M Cooper
Journal:  Radiology       Date:  1985-09       Impact factor: 11.105

9.  Prognostic factors in acute pancreatitis.

Authors:  S L Blamey; C W Imrie; J O'Neill; W H Gilmour; D C Carter
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

10.  Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.

Authors:  Zia Khan; Jane Vlodov; Joel Horovitz; Rose Mary Jose; K Iswara; Joseph Smotkin; Alphonso Brown; Scott Tenner
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  7 in total

Review 1.  Prognosis in acute pancreatitis.

Authors:  Bechien U Wu
Journal:  CMAJ       Date:  2011-03-21       Impact factor: 8.262

Review 2.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 3.  Predictors of adverse outcomes in acute pancreatitis: new horizons.

Authors:  Rupjyoti Talukdar; D Nageshwar Reddy
Journal:  Indian J Gastroenterol       Date:  2013-03-12

4.  The Relationship Between Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios With Hospital Stays and Mortality in the Emergency Department.

Authors:  Mustafa Cifci; Huseyin C Halhalli
Journal:  Cureus       Date:  2020-12-20

5.  Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis.

Authors:  Tao Cheng; Bo-Fu Liu; Tian-Yong Han; Zhi-Han Gu; Pan Pan; Haifang Yu
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

6.  Effectiveness and safety of Liuhedan for treating acute pancreatitis: A protocol for systematic review and meta analysis.

Authors:  Tao Cheng; Bo-Fu Liu; Tian-Yong Han; Zhi-Han Gu; Pan Pan; Yu Haifang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

7.  Comparison of clinical characteristics and outcomes between alcohol-induced and gallstone-induced acute pancreatitis: An Australian retrospective observational study.

Authors:  Santiago Cegarra Garcia; Michael Toolis; Max Ubels; Taha Mollah; Eldho Paul; Ashish Pandey; Brandon Thia; Tricia Wong; Ravindranath Tiruvoipati
Journal:  SAGE Open Med       Date:  2021-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.